Loading...
Header Logo
Keywords
Last Name
Institution

Patrick Joseph Medina

TitleProfessor
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentMedicine Hematology/Oncology
Address1110 N Stonewall Ave
Oklahoma City OK 73117-1200
Phone405/271-6878
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Baxley A, Lee Z, Medina P. Systemic hypersensitivity to fosaprepitant - A report of two cases. J Oncol Pharm Pract. 2016 Nov 21. PMID: 27872331.
      View in: PubMed
    2. Ignoffo R, Knapp K, Barnett M, Barbour SY, D'Amato S, Iacovelli L, Knudsen J, Koontz SE, Mancini R, McBride A, McCauley D, Medina P, O'Bryant CL, Scarpace S, Stricker S, Trovato JA. Board-Certified Oncology Pharmacists: Their Potential Contribution to Reducing a Shortfall in Oncology Patient Visits. J Oncol Pract. 2016 Apr; 12(4):e359-68. PMID: 27006358.
      View in: PubMed
    3. Medina PJ, Adams VR. PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses. Pharmacotherapy. 2016 Mar; 36(3):317-34. PMID: 26822752.
      View in: PubMed
    4. Baxley AA, Kumm DE, Bishop CB, Medina PJ, Holter-Chakrabarty J. Severe infusion reactions to brentuximab vedotin in two patients with Hodgkin lymphoma previously treated with allogeneic stem cell transplantation. J Oncol Pharm Pract. 2013 Sep; 19(3):279-83. PMID: 23154572.
      View in: PubMed
    5. Hopps S, Medina P, Pant S, Webb R, Moorman M, Borders E. Cetuximab hypersensitivity infusion reactions: Incidence and risk factors. J Oncol Pharm Pract. 2013 Sep; 19(3):222-7. PMID: 23135806.
      View in: PubMed
    6. Borders EB, Bivona C, Medina PJ. Mammalian target of rapamycin: biological function and target for novel anticancer agents. Am J Health Syst Pharm. 2010 Dec 15; 67(24):2095-106. PMID: 21116000.
      View in: PubMed
    7. Hanigan MH, Dela Cruz BL, Thompson DM, Farmer KC, Medina PJ. Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation. J Oncol Pharm Pract. 2008 Sep; 14(3):123-30. PMID: 18719067; PMCID: PMC2656681.
    8. Medina PJ, Goodin S. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases. Clin Ther. 2008 Aug; 30(8):1426-47. PMID: 18803986.
      View in: PubMed
    9. Medina MS, Medina PJ, Wanzer DS, Wilson JE, Er N, Britton ML. Use of an audience response system (ARS) in a dual-campus classroom environment. Am J Pharm Educ. 2008 Apr 15; 72(2):38. PMID: 18483604; PMCID: PMC2384213.
    10. Goodin S, Shen F, Shih WJ, Dave N, Kane MP, Medina P, Lambert GH, Aisner J, Gallo M, DiPaola RS. Clinical and biological activity of soy protein powder supplementation in healthy male volunteers. Cancer Epidemiol Biomarkers Prev. 2007 Apr; 16(4):829-33. PMID: 17416779.
      View in: PubMed
    11. Goodin S, Medina P, Capanna T, Shih WJ, Abraham S, Winnie J, Doyle-Lindrud S, Todd M, DiPaola RS. Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer. J Clin Oncol. 2005 May 20; 23(15):3352-7. PMID: 15738531.
      View in: PubMed
    12. Zondor SD, Medina PJ. Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies. Ann Pharmacother. 2004 Jul-Aug; 38(7-8):1258-64. PMID: 15187215.
      View in: PubMed
    13. Vesta KS, Medina PJ. Valproic acid-induced neutropenia. Ann Pharmacother. 2003 Jun; 37(6):819-21. PMID: 12773069.
      View in: PubMed
    14. Hibbard AB, Medina PJ, Vesely SK. Reports of drug-induced thrombocytopenia. Ann Intern Med. 2003 Feb 04; 138(3):239. PMID: 12558372.
      View in: PubMed
    15. Howard MA, Hibbard AB, Terrell DR, Medina PJ, Vesely SK, George JN. Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent). 2003 Jan; 16(1):21-6. PMID: 16278718; PMCID: PMC1200805.
    16. Zondor SD, George JN, Medina PJ. Treatment of drug-induced thrombocytopenia. Expert Opin Drug Saf. 2002 Jul; 1(2):173-80. PMID: 12904151.
      View in: PubMed
    17. Medina PJ, Sipols JM, George JN. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2001 Sep; 8(5):286-93. PMID: 11604563.
      View in: PubMed
    Medina's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _